Cargando…
The Role of HDACs as Leukemia Therapy Targets using HDI
Histone deacetylases (HDACs) are the enzymes causing deacetylation of histone and non-histone substrates. Histone deacetylase inhibitors (HDIs) are a family of drugs eliminating the effect of HDACs in malignant cells via inhibition of HDACs. Due to extensive effects upon gene expression through inte...
Autores principales: | Ahmadzadeh, Ahmad, Khodadi, Elahe, Shahjahani, Mohammad, Bertacchini, Jessika, Vosoughi, Tina, Saki, Najmaldin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Tehran University of Medical Sciences, Hematology-Oncology and Stem Cell Transplantation Research Center
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4748691/ https://www.ncbi.nlm.nih.gov/pubmed/26865932 |
Ejemplares similares
-
BRAF Mutation in Hairy Cell Leukemia
por: Ahmadzadeh, Ahmad, et al.
Publicado: (2014) -
Rare Cytogenetic Abnormalities and Alteration of microRNAs in Acute Myeloid Leukemia and Response to Therapy
por: Shahjahani, Mohammad, et al.
Publicado: (2015) -
Significance of Inactivated Genes in Leukemia:
Pathogenesis and Prognosis
por: Heidari, Nazanin, et al.
Publicado: (2017) -
Bone Marrow Blood Vessels: Normal and Neoplastic Niche
por: Shahrabi, Saeid, et al.
Publicado: (2016) -
Molecular Regulation of Bone Marrow Metastasis in Prostate and Breast Cancer
por: Rahim, Fakher, et al.
Publicado: (2014)